Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease

Mostrar otras versiones (1)

BACKGROUND AND AIM: The most effective way to control severity and mortality rate of the novel coronavirus disease (COVID-19) is through sensitive diagnostic approaches and an appropriate treatment protocol. We aimed to identify the effect of adding corticosteroid and Tocilizumab to a standard treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Qutob, Haitham M.H., Saad, Ramadan A., Bali, Hamza, Osailan, Abdulaziz, Jaber, Jumana, Alzahrani, Emad, Alyami, Jamilah, Elsayed, Hani, Alserihi, Raed, Shaikhomar, Osama A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035366/
https://www.ncbi.nlm.nih.gov/pubmed/35659421
http://dx.doi.org/10.1016/j.medcli.2022.02.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035366/
https://www.ncbi.nlm.nih.gov/pubmed/35659421
http://dx.doi.org/10.1016/j.medcli.2022.02.013

Ejemplares similares